These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19580362)

  • 1. Change in glucometer settings as a cause of sudden deterioration of glycemic control in type 2 diabetes.
    Jankovec Z; Lacigova S
    Diabetes Technol Ther; 2009 Jul; 11(7):469-70. PubMed ID: 19580362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of repaglinide addition to metformin monotherapy on glycemic control in patients with type 2 diabetes.
    Moses R; Slobodniuk R; Boyages S; Colagiuri S; Kidson W; Carter J; Donnelly T; Moffitt P; Hopkins H
    Diabetes Care; 1999 Jan; 22(1):119-24. PubMed ID: 10333912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin/Repaglinide (PrandiMet) for type 2 diabetes.
    Med Lett Drugs Ther; 2009 Jun; 51(1313):41-3. PubMed ID: 19478691
    [No Abstract]   [Full Text] [Related]  

  • 4. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
    Hay LC; Wilmshurst EG; Fulcher G
    Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting.
    Cesur M; Corapcioglu D; Gursoy A; Gonen S; Ozduman M; Emral R; Uysal AR; Tonyukuk V; Yilmaz AE; Bayram F; Kamel N
    Diabetes Res Clin Pract; 2007 Feb; 75(2):141-7. PubMed ID: 16815586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal glycemic control in type 2 diabetes mellitus: fasting and postprandial glucose in context.
    Abrahamson MJ
    Arch Intern Med; 2004 Mar; 164(5):486-91. PubMed ID: 15006824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy.
    Wang W; Bu R; Su Q; Liu J; Ning G
    Expert Opin Pharmacother; 2011 Dec; 12(18):2791-9. PubMed ID: 21780853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Continuation 50. Type 2 diabetes: possibilities and limitations of pharmacological therapy].
    Kellerer M; Jakob S; Linn T; Haslbeck M
    MMW Fortschr Med; 2003 Dec; 145(51-52):I-X; quiz XI-XII. PubMed ID: 14974337
    [No Abstract]   [Full Text] [Related]  

  • 13. Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.
    Meneghini LF; Traylor L; Schwartz SL
    Endocr Pract; 2010; 16(4):588-99. PubMed ID: 20350924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repaglinide plus single-dose insulin glargine: a safe regimen for low-risk type 2 diabetic patients who insist on fasting in Ramadan.
    Bakiner O; Ertorer ME; Bozkirli E; Tutuncu NB; Demirag NG
    Acta Diabetol; 2009 Mar; 46(1):63-5. PubMed ID: 18825302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure.
    Altuntas Y; Ozen B; Ozturk B; Sengul A; Ucak S; Ersoy O; Karul S
    Diabetes Obes Metab; 2003 Nov; 5(6):371-8. PubMed ID: 14617222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of repaglinide and metformin versus metformin alone for type 2 diabetes: a meta-analysis of randomized controlled trials.
    Yin J; Deng H; Qin S; Tang W; Zeng L; Zhou B
    Diabetes Res Clin Pract; 2014 Sep; 105(3):e10-5. PubMed ID: 25005849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of insulin glargine added to a fixed-dose combination of metformin and a dipeptidyl peptidase-4 inhibitor: results of the GOLD observational study.
    Seufert J; Pegelow K; Bramlage P
    Vasc Health Risk Manag; 2013; 9():711-7. PubMed ID: 24259985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Repaglinide (NN-623)].
    Kaku K
    Nihon Rinsho; 1997 Nov; 55 Suppl():180-5. PubMed ID: 9434464
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic control after hospital discharge in insulin-treated type 2 diabetes: a randomized pilot study of daily remote glucose monitoring.
    Wei NJ; Nathan DM; Wexler DJ
    Endocr Pract; 2015 Feb; 21(2):115-21. PubMed ID: 25148814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home glucose monitoring makes little difference in type 2 diabetes.
    J Fam Pract; 2005 Nov; 54(11):936. PubMed ID: 16299946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.